Biological half-life

The biological half-life of a substance is the amount of time it takes for the concentration of that substance in the body to be reduced by half. The biological half-life is critical in pharmacology as it helps guide dosage and frequency decisions for drug treatments. Understanding the concept of biological half-life is essential in many fields, such as pharmacokinetics, toxicology, and environmental health.

Biological atlas (Plate XXII) (6441478151)

Definition and Importance

• The Biological Half-Life refers to the time taken for the quantity of a substance within a living organism to decrease by 50%. It serves as a measure of the rate at which the body eliminates the substance. In pharmacology, this measurement is crucial for determining the duration and frequency of drug dosing to maintain therapeutic drug levels while minimizing side effects.

• The biological half-life of a substance is particularly important in drugs that have a narrow therapeutic index, where slight variations in drug levels can have substantial therapeutic or toxic effects. Examples include digoxin, warfarin, and lithium.

Factors Affecting Biological Half-Life

Biological half-life can be influenced by various factors, including individual patient characteristics and the physical and chemical properties of the substance itself.

Individual Differences

Individual physiological differences such as age, sex, weight, organ function, genetic factors, and concurrent illnesses can significantly impact the biological half-life of a substance. For instance, patients with kidney disease or liver disease often experience changes in drug half-life due to alterations in drug metabolism and excretion.

Substance Characteristics

The physical and chemical properties of a substance can also impact its biological half-life. These characteristics include the drug's solubility, its volume of distribution (Vd), its protein binding ability, and the route of administration. Drugs that are highly lipophilic or have a high volume of distribution often have longer half-lives due to their ability to penetrate deep into tissues.

Measurement and Calculation

• The measurement of a substance's biological half-life usually involves taking samples (e.g., blood, urine) at various points in time after administration and analyzing these samples for the substance's concentration. This data is then plotted on a semilogarithmic plot, and the biological half-life is determined by observing the time taken for the concentration to decrease by half.
• It's also important to note that the biological half-life can be calculated if the clearance rate (CL) and volume of distribution (Vd) are known, using the equation:

Applications in Medicine

• Understanding the biological half-life of drugs plays a significant role in therapeutic drug monitoring, guiding dosage decisions, scheduling drug administration, and interpreting laboratory results. This knowledge also guides the management of drug overdose or toxicity scenarios, helping to predict the time-course of toxicity and response to treatment.
• Moreover, it is crucial for understanding and predicting drug interactions. A drug with a long biological half-life can remain in the body for extended periods and potentially interact with other medications administered later.

See Also

• Pharmacokinetics
• Pharmacodynamics
• Therapeutic Drug Monitoring
• Volume of Distribution
• Clearance (pharmacology)

References

• Rang, H. P., & Dale, M. M. (2015). Rang & Dale's pharmacology (8th ed.). Edinburgh: Churchill Livingstone.
• Laurence, D. R., & Bennett, P. N. (1992). Clinical Pharmacology (7th ed.). Churchill Livingstone.
• Rowland, M., & Tozer, T. N. (2011). Clinical pharmacokinetics and pharmacodynamics: concepts and applications (4th ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins.

Biological half-life Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski